- Home
- SABS vs PRPH Comparison
SABS vs PRPH Comparison
Compare SABS & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- PRPH
- Stock Information
- Founded
- SABS 2014
- PRPH 1989
- Country
- SABS United States
- PRPH United States
- Employees
- SABS N/A
- PRPH N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- SABS Health Care
- PRPH Health Care
- Exchange
- SABS Nasdaq
- PRPH Nasdaq
- Market Cap
- SABS 11.4M
- PRPH 10.7M
- IPO Year
- SABS N/A
- PRPH 1997
- Fundamental
- Price
- SABS $1.75
- PRPH $0.37
- Analyst Decision
- SABS Strong Buy
- PRPH
- Analyst Count
- SABS 5
- PRPH 0
- Target Price
- SABS $11.40
- PRPH N/A
- AVG Volume (30 Days)
- SABS 25.4K
- PRPH 2.4M
- Earning Date
- SABS 05-19-2025
- PRPH 05-08-2025
- Dividend Yield
- SABS N/A
- PRPH N/A
- EPS Growth
- SABS N/A
- PRPH N/A
- EPS
- SABS N/A
- PRPH N/A
- Revenue
- SABS $1,322,410.00
- PRPH $6,770,000.00
- Revenue This Year
- SABS N/A
- PRPH $221.82
- Revenue Next Year
- SABS $50.00
- PRPH N/A
- P/E Ratio
- SABS N/A
- PRPH N/A
- Revenue Growth
- SABS N/A
- PRPH N/A
- 52 Week Low
- SABS $1.00
- PRPH $0.22
- 52 Week High
- SABS $5.01
- PRPH $7.48
- Technical
- Relative Strength Index (RSI)
- SABS 63.35
- PRPH 53.48
- Support Level
- SABS $1.30
- PRPH $0.26
- Resistance Level
- SABS $1.49
- PRPH $0.38
- Average True Range (ATR)
- SABS 0.14
- PRPH 0.06
- MACD
- SABS 0.06
- PRPH 0.01
- Stochastic Oscillator
- SABS 100.00
- PRPH 57.27
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.